Local therapy and survival in breast cancer with distant metastases

Journal of Surgical Oncology

Volumn 105, Issue 1, 2012, Pages 104-110

  Noguchi, Masakuni ^a   Nakano, Yasuharu ^a   Noguchi, Miki ^a   Ohno, Yukako ^a   Kosaka, Takeo ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Breast cancer; Local therapy; Oligometastases; Stereotactic body radiotherapy

Indexed keywords

BREAST CANCER; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CLINICAL TRIAL; DISTANT METASTASIS; HUMAN; LIVER METASTASIS; LUNG METASTASIS; METASTASIS; MULTIMODALITY CANCER THERAPY; OLIGOMETASTASIS; PATIENT SELECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; REVIEW; STEREOTACTIC BODY RADIATION THERAPY; SYSTEMIC THERAPY;

BREAST NEOPLASMS; FEMALE; HUMANS; SURVIVAL RATE;

EID: 80655124842     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.22056     Document Type: Review

References (88)

1. Sledge GW,: Should we dream the impossible dream? The meaning of long-term survival in metastatic breast cancer. J Clin Oncol 1996; 14: 2191-2193. (Pubitemid 26264867)
2. Hortobagyi GN,: Can we cure limited metastatic breast cancer? J Clin Oncol 2002; 20: 620-623. (Pubitemid 34111365)
3. Friedel G, Pastprino U, Ginsberg RJ, et al.: Results of lung metastasectomy from breast cancer: Prognostic criteria on the basis of 467 cases of the International Registry of Lung Metastases. Eur J Cardiothorac Surg 2002; 22: 335-344. (Pubitemid 36153060)
4. Greenberg PA, Hortobagyi GN, Smith TL, et al.: Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer. J Clin Oncol 1996; 14: 2197-2205. (Pubitemid 26264869)
5. Nabholtz JM, Lindsay MA, Hugh J, et al.: The academic global virtual concept in clinical cancer research and its application to breast cancer: The breast cancer International Research Group. Semin Oncol 1999; 26: 4-8. (Pubitemid 29314183)
6. Hortobagyi GN,: Treatment of breast cancer. N Engl J Med 1998; 339: 974-984. (Pubitemid 28455101)
7. Bafford AC, Burstein HJ, Barkley CR, et al.: Breast surgery in stage IV breast cancer: Impact of staging and patient selection on overall survival. Breast Cancer Res Treat 2009; 115: 7-12.
8. Lermite E, Marzano E, Chereau E, et al.: Surgical resection of liver metastases from breast cancer. Surg Oncol 2010; 19: e79-e84.
9. Howlader M, Heaton N, Rela M,: Resection of liver metastases from breast cancer: Towards a management guideline. Int J Surg 2011; 9: 285-291.
10. Andre F, Slimane K, Bachelot T, et al.: Breast cancer with synchronous metastases: Trends in survival during a 14-year period. J Clin Oncol 2004; 22: 3302-3308. (Pubitemid 41103686)
11. Bland KI, Copeland EM,: The breast: Comprehensive management of benign and malignant diseases, 2nd edition. New York, NY: W.B. Saunders Company; 1998.
12. Khan SA, Steward AK, Morrow M,: Does aggressive local therapy improve survival in metastatic breast cancer? Surgery 2002; 132: 620-627. (Pubitemid 35247324)
13. Gnerlich J, Jeffe DB, Deshpande AD, et al.: Surgical removal of the primary tumor increase overall survival in patients with metastatic breast cancer: Analysis of the 1988-2003 SEER data. Ann Surg Oncol 2007; 14: 2187-2194. (Pubitemid 47174926)
14. Rapiti E, Verkooijen HM, Vlastos G, et al.: Complete excision of primary breast tumor improves survival of patients with metastatic breast cancer at diagnosis. J Clin Oncol 2006; 24: 2743-2749. (Pubitemid 46630571)
15. Babiera GV, Rao R, Feng L, et al.: Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor. Ann Surg Oncol 2006; 13: 776-782. (Pubitemid 43727360)
16. Blanchard DK, Shetty PB, Hilsenbeck SG, et al.: Association of surgery with improved survival in stage IV breast cancer patients. Ann Surg 2008; 247: 732-738. (Pubitemid 351591506)
17. Fields RC, Jeffe DB, Trinkaus K, et al.: Surgical resection of the primary tumor is associated with increased long-term survival in patients with stage IV breast cancer after controlling for site of metastasis. Ann Surg Oncol 2007; 14: 3345-3351. (Pubitemid 350160108)
18. Hazard HW, Gorla SR, Scholtens D, et al.: Surgical resection of the primary tumor, chest wall control, and survival in women with metastatic breast cancer. Cancer 2008; 113: 2011-2019.
19. Neuman HB, Morrogh M, Gonen M, et al.: Stage IV breast cancer in the era of targeted therapy. Cancer 2010; 116: 1226-1233.
20. Ruiterkamp J, Ernst MF, van de Poll-Franse LV, et al.: Surgical resection of the primary tumour is associated with improved survival in patients with distant metastatic breast cancer at diagnosis. Eur J Surg Oncol 2009; 35: 1146-1151.
21. Leung AM, Vu HN, Nguyen KA, et al.: Effects of surgical excision on survival of patients with stage IV breast cancer. J Surg Res 2010; 161: 83-88.
22. Cady B, Nathan NR, Michaelson JS, et al.: Matched pair analyses of stage IV breast cancer with or without resection of primary breast site. Ann Surg Oncol 2008; 15: 3384-3395.
23. Shien T, Kinoshita T, Shimizu C, et al.: Primary tumor resection improves the survival of younger patients with metastatic breast cancer. Oncol Rep 2009; 21: 827-832.
24. Le Scodan R, Stevens D, Brain E, et al.: Breast cancer with synchronous metastases: Survival impact of exclusive locoregional radiotherapy. J Clin Oncol 2009; 27: 1375-1381.
25. Griffiths CT, Parker LM, Lee S, et al.: The effect of residual mass size on response to chemotherapy after surgical cytoreduction for advanced ovarian cancer: Long-term results. Int J Gynecol Cancer 2002; 12: 323-331. (Pubitemid 34839829)
26. Martin R, Paty P, Fong Y, et al.: Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis. J Am Coll Surg 2003; 197: 233-241.
27. Rosen SA, Buell JF, Yoshida A, et al.: Initial presentation with stage IV colorectal cancer: How aggressive should we be? Arch Surg 2000; 135: 530-534.
28. Tanaka K, Shimada H, Matsuo K, et al.: Outcome after simultaneous colorectal and hepatic resection for colorectal cancer with synchronous metastases. Surgery 2004; 136: 650-659. (Pubitemid 39186580)
29. Ragaz J, Jackson SM, Le N, et al.: Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 1997; 337: 956-962. (Pubitemid 27425951)
30. Overgaard M, Hansen PS, Overgaard J, et al.: Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 1997; 337: 949-955. (Pubitemid 27425950)
31. Overgaard M, Jensen MB, Overgaard J, et al.: Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomized trial. Lancet 1999; 353: 1641-1648. (Pubitemid 29224519)
32. Fisher B, Anderson SJ,: The breast cancer alternative hypothesis: Is there evidence to justify replacing it? J Clin Oncol 2010; 28: 366-374.
33. Noguchi M,: Does regional treatment improve the survival in patients with operable breast cancer? Breast Cancer Res Treat 2002; 76: 269-282. (Pubitemid 35335216)
34. Hellman S,: Stopping metastases at their source. N Engl J Med 1997; 337: 996-997. (Pubitemid 27425957)
35. Whelan TJ, Julian J, Wright J, et al.: Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis. J Clin Oncol 2000; 18: 1220-1229. (Pubitemid 30159839)
36. Soran A, Ozbas S, Kelsey SF, et al.: Randomized trial comparing locoregional resection of primary tumor with no surgery in stage IV breast cancer at the presentation (protocol MF07-01): A study of Turkish federation of the National societies for breast diseases. Breast J 2009; 15: 399-403.
37. Parmar V, Hawaldar RW, Pandey N, et al.: Surgical removal of primary tumor in women with metastatic breast cancer-Is it really justified ? ASCO Breast Cancer Symposium 2009, abstract 323.
38. Le Scodan R, Ali D, Stevens D,: Exclusive and adjuvant radiotherapy in breast cancer patients with synchronous metastases. BMC Cancer 2010; 10: 630.
39. Rivera E, Holmes FA, Buzdar AU, et al.: Fluorouracil, doxorubicin, and cyclophosphamide followed by tamoxifen as adjuvant treatment for patients with stage IV breast caner with no evidence of disease. Breast J 2002; 8: 2-9. (Pubitemid 34118477)
40. Bergh J, Jonsson PE, Glimelius B, et al.: Swedish Council of Technology Assessment in Health Care. A systemic overview of chemotherapy effects in breast cancer. Acta Oncol 2001; 40: 253-281.
41. Stockler M, Wilcken NR, Ghersi D, et al.: Systemic reviews of chemotherapy and endocrine therapy in metastatic breast cancer. Cancer Treat Rev 2000; 26: 151-168. (Pubitemid 30330662)
42. Tait CR, Waterworth A, Loncaster J, et al.: The oligometastatic state in breast cancer: Hypothesis or reality. The Breast 2005; 14: 87-93. (Pubitemid 40353035)
43. McDonald ML, Deschamps C, Ilstrup DM, et al.: Pulmonary resection for metastatic breast cancer. Ann Thorac Surg 1994; 58: 1599-1602. (Pubitemid 24378963)
44. Welter S, Jacobs J, Krbek T, et al.: Pulmonary metastases of breast cancer. When is resection indicated? Eur J Cardiothorac Surg 2008; 34: 1228-1234.
45. Staren ED, Salerno C, Rongione A, et al.: Pulmonary resection for metastatic breast cancer. Arch Surg 1992; 127: 1282-1284.
46. Lanza LA, Natarajan G, Roth JA, et al.: Long-term survival after resection of pulmonary metastasis from carcinoma of the breast. Am Thorac Surg 1992; 54: 244-248.
47. Yoshimoto M, Tada K, Nishimura S, et al.: Favourable long-term results after surgical removal of lung metastases of breast cancer. Breast Cancer Res Treat 2008; 110: 485-491. (Pubitemid 351962594)
48. Friedel G, Linder A, Toomes U,: The significance of prognostic factors for the resection of pulmonary metastases of breast cancer. Thorac Cardiovasc 1994; 42: 71-75. (Pubitemid 24150561)
49. Salat A, Murabito M, Groeger A, et al.: Significant extension of survival by complete resection of isolated lung metastases after breast carcinoma. Chirurg 1998; 69: 735-740. (Pubitemid 128539048)
50. Planchard D, Soria J-C, Michiels S, et al.: Uncertain benefit from surgery in patients with lung metastases from breast carcinoma. Cancer 2004; 100: 28-35. (Pubitemid 37553536)
51. Livartowski A, Chapelier A, Beuzeboc P, et al.: Surgical excision of pulmonary metastasis of cancer of the breast: Apropos of 40 patients. Bull Cancer 1998; 85: 799-802.
52. Kiang DT, Kennedy BJ, Younger J, et al.: Alternating chemotherapy regimens for patients with metastatic breast cancer. Cancer 1995; 75: 826-830.
53. Piccart MJ,: Docetaxel: A new defense in the management of breast cancer. Anti-Cancer Drugs 1995; 6: 7-11.
54. Pouillart P, Jouvert M, Palangie T, et al.: Hepatic metastases in cancer of the breast. Analysis of parameters acting response to chemotherapy. Ann Gastroenterol Hepatol 1985; 21: 87-90. (Pubitemid 15075412)
55. Raab R, Nussbaum KT, Behrend M, et al.: Liver metastases of breast cancer: Results of liver resection. Anticancer Res 1998; 18: 2231-2233. (Pubitemid 28386496)
56. Yoshimoto M, Tada T, Saito M, et al.: Surgical treatment of hepatic metastases from breast cancer. Breast Cancer Res Treat 2000; 59: 177-184. (Pubitemid 30216141)
57. Pocard M, Pouillart P, Asselain B, et al.: Hepatic resection for breast cancer metastases: Results and prognosis (65 cases). Ann Chir 2001; 126: 413-420. (Pubitemid 32538828)
58. Elias D, Maisonnette F, Druet-Cabanac M, et al.: An attempt to clarify indications for hepatectomy for liver metastases from breast cancer. Am J Surg 2003; 185: 158-164. (Pubitemid 36143907)
59. Vlastos G, Smith DL, Singletary SE, et al.: Long-term survival after an aggressive surgical approach in patients with breast cancer hepatic metastases. Ann Surg Oncol 2004; 11: 869-874.
60. Sakamoto Y, Yamamoto J, Yoshimoto M, et al.: Hepatic resection for metastatic breast cancer: Prognostic analysis of 34 patients. World J Surg 2005; 29: 524-527. (Pubitemid 41125381)
61. Adam R, Aloia T, Krissat J, et al.: Is liver resection justified for patients with hepatic metastases from breast cancer? Ann Surg 2006; 244: 897-908.
62. Adam R, Chiche L, Aloia T, et al.: Hepatic resection for noncolorectal nonendocrine liver metastases: Analysis of 1452 patients and development of a prognostic model. Ann Surg 2006; 244: 524-535.
63. Ercolani G, Grazi GL, Ravaioli M, et al.: The role of liver resections for noncolorectal, nonneuroendocrine metastases: Experience with 142 observed cases. Ann Surg Oncol 2005; 12: 459-466. (Pubitemid 40884260)
64. Hoffmann K, Franz C, Hinz U, et al.: Liver resection for multimodal treatment of breast cancer metastases: Identification of prognostic factors. Surg Oncol 2010; 17: 1546-1554.
65. Thelen A, Benckert C, Jonas S, et al.: Liver resection for metastases from breast cancer. J Surg Oncol 2008; 97: 25-29.
66. Kollmar O, Moussavian MR, Richter S, et al.: Surgery of liver metastasis in gynecological cancer-indication and results. Onkologie 2008; 31: 375-379. (Pubitemid 351967574)
67. O'Reilly SM, Richards MA, Rubens RD,: Liver metastases from breast cancer: The relationship between clinical, biochemical and pathological features and survival. Eur J Cancer 1990; 26: 574-577. (Pubitemid 20259332)
68. Cutler SJ, Ardyce JA, Taylor SG,: Classification of patients with disseminated cancer of breast. Cancer 1969; 24: 861-869.
69. Goldhrisch A, Gelber RD, Castiglione M,: Relapse of breast cancer after adjuvant treatment in premenopausal and perimenopausal women: Patterns and prognoses. J Clin Oncol 1988; 6: 89-99.
70. Wyld L, Gutteridge E, Pinder SE, et al.: Prognostic factors for patients with hepatic metastases from breast cancer. Br J Cancer 2003; 89: 284-290. (Pubitemid 36976317)
71. Yamamoto J, Shimada K, Kosuge T, et al.: Factors influencing survival of patients undergoing hepatectomy for colorectal metastases. Br J Surg 1999; 86: 332-337. (Pubitemid 29145918)
72. Minagawa M, Makuuchi M, Torzilli G, et al.: Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer. Ann Surg 2000; 231: 487-499. (Pubitemid 30185854)
73. MacDermed DM, Weichselbaum RR, Salama J,: A rationale for the targeted treatment of oligometastases with radiotherapy. J Surg Onocl 2008; 98: 202-206.
74. Pan H, Simpson DR, Mell LK, et al.: A survey of stereotactic body radiotherapy use in the United States. Cancer 2011; Mar 15. DOI: 10.1002/cncr.26067 [Epub ahead of print].
75. Milano MT, Zhang H, Metcalfe SK, et al.: Oligometastatic breast cancer treated with curative-intent stereotactic body radiation therapy. Breast Cancer Res Treat 2009; 115: 601-608.
76. Katz AW, Carey-Sampson M, Muhs AG, et al.: Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases. Int J Radiat Oncol Biol Phys 2007; 67: 793-798. (Pubitemid 46215888)
77. Fisher B,: Laboratory and clinical research in breast cancer: A personal adventure-The David A. Karnofsky memorial lecture. Cancer Res 1980; 40: 3863-3874. (Pubitemid 11234057)
78. Hellman S, Weichselbaum RR,: Oligometastases. J Clin Oncol 1995; 13: 8-10.
79. Punglia RS, Morrow M, Winer EP, et al.: Local therapy and survival in breast cancer. N Engl J Med 2007; 356: 2399-2405.
80. Hellman S,: Karnofsky memorial lecture: Natural history of small breast cancers. J Clin Oncol 1994; 12: 2229-2234. (Pubitemid 24356043)
81. Carey Sampson M, Katz A, Constine LS,: Stereotactic body radiation therapy for extracranial oligometastases: Does the sword have a double edge? Semin Radiat Oncol 2006; 16: 67-76.
82. Niibe Y, Hayakawa K,: Oligometastases and oligo-recurrence: The new era of cancer therapy. Jpn J Clin Oncol 2010; 40: 107-111.
83. Krag DN, Ashikaga T, Moss TJ, et al.: Breast cancer cells in the blood: A pilot study. Breast J 1999; 5: 354-358.
84. Beitsch P, Clifford E,: Detection of carcinoma cells in the blood of breast cancer patients. Am J Surg 2000; 180: 446-449. (Pubitemid 32166836)
85. Pollock RE, Roth JA,: Cancer-induced immunosuppression: Implications for therapy? Sem Surg Oncol 1989; 5: 414-419. (Pubitemid 20052556)
86. Kavanaugh DY, Carbone DP,: Immunologic dysfunction in cancer. Hematol Oncol Clin North Am 1996; 10: 927-951. (Pubitemid 26240366)
87. Muss HB,: Chemotherapy of gynecologic cancer, 2nd edition. New York: Wiley-Liss; 1990.
88. Marks LB, Prosnitz LR,: Postoperative radiotherapy for lung cancer: The breast cancer story all over again? Int J Radiat Oncol Biol Phys 2000; 48: 625-627.